{"title":"基于Salep多糖的多反应纳米凝胶控制阿霉素释放：结构表征和靶向乳腺癌治疗的功能评价","authors":"Ghasem Rezanejade Bardajee, Hossein Mahmoodian, Negin Shafiei, Mahnaz Rouhi, Golnaz Sang, Mohammad Amin Karimi","doi":"10.1007/s12247-025-09962-x","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Effective drug delivery remains a significant challenge in breast cancer therapy. This study was designed to develop a salep polysaccharide-based multi-responsive nanogel (NG) for the controlled delivery of doxorubicin (DOX) to breast cancer cells, with the goal of enhancing targeted treatment and reducing systemic toxicity.</p><h3>Methods</h3><p>The NG was synthesized using radical precipitation/dispersion polymerization, incorporating magnetic graphene oxide (MGO), N-isopropylacrylamide (NIPAM), 2-dimethylaminoethyl acrylate (DMAEA), and a redox-responsive crosslinker, N,N’-Bis(acryloyl)cystamine (BAC). Structural characterization by DLS and TEM confirmed a semi-spherical morphology, with a mean hydrodynamic diameter of approximately 78 nm and a polydispersity index (PDI) of 0.335. FT-IR, EDAX, and XRD validated the successful incorporation of components while SEM and AFM provided detailed insights into the surface morphology.</p><h3>Results</h3><p>The NG demonstrated a high DOX loading capacity (92%) and an efficient drug release profile. Under acidic (pH 5) and reductive (10 mM glutathione) conditions, 96% of DOX was released, decreasing the drug release time from 10 hours to approximately 60 minutes. The release kinetics were consistent with the Korsmeyer-Peppas model, indicative of Fickian diffusion. Furthermore, cytotoxicity evaluations using the MTT assay revealed low toxicity in normal MCF-10A cells, supporting the potential of the NG to improve therapeutic efficacy while minimizing adverse effects.</p><h3>Conclusion</h3><p>The salep polysaccharide-based multi-responsive NG represents a promising targeted drug delivery system for breast cancer therapy. Its high DOX loading capacity, rapid and controlled drug release under tumor-like conditions, and minimal toxicity underscore its potential to advance the application of biopolymer-based nanogels in precision oncology.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"20 3","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Salep Polysaccharide-Based Multi-Responsive Nanogel for Controlled Doxorubicin Release: Structural Characterization and Functional Evaluation for Targeted Breast Cancer Therapy\",\"authors\":\"Ghasem Rezanejade Bardajee, Hossein Mahmoodian, Negin Shafiei, Mahnaz Rouhi, Golnaz Sang, Mohammad Amin Karimi\",\"doi\":\"10.1007/s12247-025-09962-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Effective drug delivery remains a significant challenge in breast cancer therapy. This study was designed to develop a salep polysaccharide-based multi-responsive nanogel (NG) for the controlled delivery of doxorubicin (DOX) to breast cancer cells, with the goal of enhancing targeted treatment and reducing systemic toxicity.</p><h3>Methods</h3><p>The NG was synthesized using radical precipitation/dispersion polymerization, incorporating magnetic graphene oxide (MGO), N-isopropylacrylamide (NIPAM), 2-dimethylaminoethyl acrylate (DMAEA), and a redox-responsive crosslinker, N,N’-Bis(acryloyl)cystamine (BAC). Structural characterization by DLS and TEM confirmed a semi-spherical morphology, with a mean hydrodynamic diameter of approximately 78 nm and a polydispersity index (PDI) of 0.335. FT-IR, EDAX, and XRD validated the successful incorporation of components while SEM and AFM provided detailed insights into the surface morphology.</p><h3>Results</h3><p>The NG demonstrated a high DOX loading capacity (92%) and an efficient drug release profile. Under acidic (pH 5) and reductive (10 mM glutathione) conditions, 96% of DOX was released, decreasing the drug release time from 10 hours to approximately 60 minutes. The release kinetics were consistent with the Korsmeyer-Peppas model, indicative of Fickian diffusion. Furthermore, cytotoxicity evaluations using the MTT assay revealed low toxicity in normal MCF-10A cells, supporting the potential of the NG to improve therapeutic efficacy while minimizing adverse effects.</p><h3>Conclusion</h3><p>The salep polysaccharide-based multi-responsive NG represents a promising targeted drug delivery system for breast cancer therapy. Its high DOX loading capacity, rapid and controlled drug release under tumor-like conditions, and minimal toxicity underscore its potential to advance the application of biopolymer-based nanogels in precision oncology.</p><h3>Graphical Abstract</h3>\\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>\",\"PeriodicalId\":656,\"journal\":{\"name\":\"Journal of Pharmaceutical Innovation\",\"volume\":\"20 3\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Innovation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12247-025-09962-x\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-025-09962-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Salep Polysaccharide-Based Multi-Responsive Nanogel for Controlled Doxorubicin Release: Structural Characterization and Functional Evaluation for Targeted Breast Cancer Therapy
Purpose
Effective drug delivery remains a significant challenge in breast cancer therapy. This study was designed to develop a salep polysaccharide-based multi-responsive nanogel (NG) for the controlled delivery of doxorubicin (DOX) to breast cancer cells, with the goal of enhancing targeted treatment and reducing systemic toxicity.
Methods
The NG was synthesized using radical precipitation/dispersion polymerization, incorporating magnetic graphene oxide (MGO), N-isopropylacrylamide (NIPAM), 2-dimethylaminoethyl acrylate (DMAEA), and a redox-responsive crosslinker, N,N’-Bis(acryloyl)cystamine (BAC). Structural characterization by DLS and TEM confirmed a semi-spherical morphology, with a mean hydrodynamic diameter of approximately 78 nm and a polydispersity index (PDI) of 0.335. FT-IR, EDAX, and XRD validated the successful incorporation of components while SEM and AFM provided detailed insights into the surface morphology.
Results
The NG demonstrated a high DOX loading capacity (92%) and an efficient drug release profile. Under acidic (pH 5) and reductive (10 mM glutathione) conditions, 96% of DOX was released, decreasing the drug release time from 10 hours to approximately 60 minutes. The release kinetics were consistent with the Korsmeyer-Peppas model, indicative of Fickian diffusion. Furthermore, cytotoxicity evaluations using the MTT assay revealed low toxicity in normal MCF-10A cells, supporting the potential of the NG to improve therapeutic efficacy while minimizing adverse effects.
Conclusion
The salep polysaccharide-based multi-responsive NG represents a promising targeted drug delivery system for breast cancer therapy. Its high DOX loading capacity, rapid and controlled drug release under tumor-like conditions, and minimal toxicity underscore its potential to advance the application of biopolymer-based nanogels in precision oncology.
期刊介绍：
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:
Materials science,
Product design,
Process design, optimization, automation and control,
Facilities; Information management,
Regulatory policy and strategy,
Supply chain developments ,
Education and professional development,
Journal of Pharmaceutical Innovation publishes four issues a year.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
